VENN STRATEGIES

Lobbying for PACIRA PHARMACEUTICALS INC. · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Improving access to non-opioid approaches to pain management.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem